Johannes has over 25 years’ experience in the biopharmaceutical industry. He has held leadership positions in Research & Development, Regulatory Affairs, Clinical Operations, Facilities, Engineering and Development of Manufacturing Facilities in small, medium, and large biopharmaceutical companies in Germany, Canada, USA, and Ireland.
Johannes is the CEO and founder Cilatus BioPharma, a CMC Development, Manufacturing, Regulatory Affairs and Quality consulting company based in Switzerland serving biopharmaceutical clients in the US and Europe. Prior to founding Cilatus, Johannes served as Executive Vice President, Head of Operations and Site Manager for Elan Pharmaceutical International, was one of the co-founding Executives of Prothena Bioscience, and also held Senior Management positions at Genentech, Biogen, IDEC Pharmaceuticals, and Bayer.
Johannes earned his Ph.D. in Chemical Engineering from Clemson University, SC, USA and his Dipl.-Ing. Verfahrenstechnik from RWTH in Aachen, Germany.